Healthcare company PureTech and US-based Nektar Therapeutics have terminated merger talks only four days after they announced a potential tie up.
“These discussions were early in nature and the required announcement created the impression that discussions were more advanced than they were,” PureTech said on Tuesday.
“Given the early stage of the discussions and the potential for an extended period of uncertainty, these discussions were terminated.”
Reporting by Frank Prenesti for Sharecast.com
